1. Medtech Insight
  2. >>Business

Exec Chat: M Holland's Josh Blackmore On Plastics' Hard Impact On Medtech Innovation

 
• By Reed Miller

Josh Blackmore recently joined M Holland Co., a leading distributor of thermoplastic resin, as its global healthcare manager to help expand the company's participation in the medical device industry. He provides insight on the importance of plastics and how this material plays an important role in helping to drive medical device-makers innovate.

Interview

Plastic is so common that it may often be overlooked as an important driver of innovation in the history of medical technology, but it is not overlooked by companies trying to develop new devices or make existing devices easier to use, safer, or more cost-effective.

To respond to the medical device-makers' need for technical expertise on plastic, suppliers of this material are looking to expand more into the medtech field and help device-makers with product...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Business

More from Medtech Insight

TRiCares Tricuspid Valve Replacement System Reduces Regurgitation In First-In-Human Study

 
• By Natasha Barrow

TRiCares presented data from the first-in-human study for its tricuspid valve replacement system – Topaz – at EuroPCR 2025 on 22 May.

Swiss Medtechs Advised To Work On US Tariff Mitigation Strategies

 
• By Ashley Yeo

The US’ 90-day suspension of higher “reciprocal tariffs” will expire on 9 July, raising fears that the 31% tariff rate on Swiss medtech and other goods exported to the US might make a comeback. While the tariff situation changes on an almost daily basis, medtechs should forearm for any eventually, say local business organizations.

Guardant Health Launches Germline Hereditary Cancer Test

 
• By Natasha Barrow

Guardant Health introduces a new germline panel test to help guide cancer treatment, assess the risk of secondary cancers in patients and identify family members at risk of cancer.